Association of HTR2A polymorphisms with chronic widespread pain and the extent of musculoskeletal pain: Results from two population-based cohorts

Arthritis and Rheumatism

Volumn 63, Issue 3, 2011, Pages 810-818

  Nicholl, Barbara I ^a,b   Holliday, Kate L ^b   MacFarlane, Gary J ^c   Thomson, Wendy ^b   Davies, Kelly A ^b   O'Neill, Terence W ^b   Bartfai, Gyorgy ^d   Boonen, Steven ^e   Casanueva, Felipe F ^f   Finn, Joseph D ^b   Forti, Gianni ^g   Giwercman, Aleksander ^h,i   Huhtaniemi, Ilpo T ^j   Kula, Krzysztof ^k   Punab, Margus ^l   Silman, Alan J ^b   Vanderschueren, Dirk ^e   Wu, Frederick C W ^m   McBeth, John ^b  

^a KEELE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d UNIVERSITY OF SZEGED   (Hungary)

^e UNIVERSITY OF LEUVEN   (Belgium)

^f HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^g UNIVERSITY OF FLORENCE   (Italy)

^h LUND UNIVERSITY HOSPITAL   (Sweden)

ⁱ LUND UNIVERSITY   (Sweden)

^j IMPERIAL COLLEGE LONDON   (United Kingdom)

^k MEDICAL UNIVERSITY OF LODZ   (Poland)

^l TARTU UNIVERSITY CLINICS   (Estonia)

^m MANCHESTER ROYAL INFIRMARY   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DNA; SEROTONIN RECEPTOR; SEROTONIN RECEPTOR 2A; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; BECK DEPRESSION INVENTORY; CHRONIC PAIN; CHRONIC WIDESPREAD PAIN; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL PAIN; PAIN ASSESSMENT; PHENOTYPE; POPULATION RESEARCH; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; CHRONIC PAIN; COHORT STUDIES; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MUSCULOSKELETAL PAIN; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEVERITY OF ILLNESS INDEX; TRYPTOPHAN HYDROXYLASE;

EID: 79953678962     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30185     Document Type: Article

References (34)

1. Ciccone DS, Elliott DK, Chandler HK, Nayak S, Raphael KG. Sexual and physical abuse in women with fibromyalgia syndrome: a test of the trauma hypothesis. Clin J Pain 2005;21:378-86. (Pubitemid 41233132)
2. Gupta A, Silman AJ, Ray D, Morriss R, Dickens C, Macfarlane GJ, et al. The role of psychosocial factors in predicting the onset of chronic widespread pain: results from a prospective population-based study. Rheumatology (Oxford) 2007;46:666-71. (Pubitemid 46523314)
3. Wood PB, Holman AJ. An elephant among us: the role of dopamine in the pathophysiology of fibromyalgia. J Rheumatol 2009;36:221-4.
4. McBeth J, Silman AJ, Gupta A, Chiu YH, Ray D, Morriss R, et al. Moderation of psychosocial risk factors through dysfunction of the hypothalamic-pituitary-adrenal stress axis in the onset of chronic widespread musculoskeletal pain: findings of a population-based prospective cohort study. Arthritis Rheum 2007;56:360-71. (Pubitemid 46106210)
5. Arnold LM, Hudson JI, Hess EV, Ware AE, Fritz DA, Auchenbach MB, et al. Family study of fibromyalgia. Arthritis Rheum 2004; 50:944-52. (Pubitemid 38326195)
6. Kato K, Sullivan PF, Evengard B, Pedersen NL. Importance of genetic influences on chronic widespread pain. Arthritis Rheum 2006; 54:1682-6.
7. Kato K, Sullivan PF, Evengard B, Pedersen NL. A population-based twin study of functional somatic syndromes. Psychol Med 2008; 39:497-505.
8. Mense S. Neurobiological concepts of fibromyalgia - the possible role of descending spinal tracts. Scand J Rheumatol Suppl 2000; 113:24-9. (Pubitemid 32016432)
9. Russell IJ, Vipraio GA, Lopez YG. Serum serotonin (5HT) in fibromyalgia syndrome, rheumatoid arthritis and healthy normal controls [abstract]. Arthritis Rheum 1993;36:S222.
10. Wolfe F, Russell IJ, Vipraio G, Ross K, Anderson J. Serotonin levels, pain threshold, and fibromyalgia symptoms in the general population. J Rheumatol 1997;24:555-9. (Pubitemid 27153424)
11. Keck PE. An open clinical trial of venlafaxine treatment of fibromyalgia. Psychosomatics 1998;39:14-7.
12. Benjamin S, Morris S, McBeth J, Macfarlane GJ, Silman AJ. The association between chronic widespread pain and mental disorder: a population-based study. Arthritis Rheum 2000;43:561-7. (Pubitemid 30394947)
13. Limer KL, Nicholl BI, Thomson W, McBeth J. Exploring the genetic susceptibility of chronic widespread pain: the tender points in genetic association studies. Rheumatology (Oxford) 2008;47:572-7. (Pubitemid 351619192)
14. Macfarlane GJ. Generalized pain, fibromyalgia and regional pain: an epidemiological view. Best Pract Res Clin Rheumatol 1999;13:403-14.
15. Lee D, O'Neill T, Pye S, Silman A, Finn J, Pendleton N, et al. The European Male Ageing Study (EMAS): design, methods and recruitment. Int J Androl 2009;32:11-24.
16. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160-72. (Pubitemid 20098653)
17. Hunt IM, Silman AJ, Benjamin S, McBeth J, Macfarlane GJ. The prevalence and associated features of chronic widespread pain in the community using the 'Manchester' definition of chronic wide-spread pain. Rheumatology (Oxford) 1999;38:275-9. (Pubitemid 29507164)
18. Beck AT, Steer RA, Carbin MG. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev 1988;8:77-100. (Pubitemid 18045797)
19. De Bakker PI, Yelensky R, Pe'er I, Gabriel SB, DalyMJ, Altshuler D. Efficiency and power in genetic association studies. Nat Genet 2005;37:1217-23. (Pubitemid 41568704)
20. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-5. (Pubitemid 40202029)
21. Macfarlane GJ, Pye SR, Finn JD, Wu FC, Silman AJ, Bartfai G, et al. Investigating the determinants of international differences in the prevalence of chronic widespread pain: evidence from the European Male Ageing Study. Ann Rheum Dis 2009;68:690-5.
22. QUANTO 1.1, a computer program for power and sample size calculations for genetic-epidemiology studies. 2006. URL: http://hydra.usc.edu/gxe.
23. Li J, Ji L. Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity 2005;95:221-7. (Pubitemid 43093236)
24. Bondy B, Spaeth M, Offenbaecher M, Glatzeder K, Stratz T, Schwarz M, et al. The T102C polymorphism of the 5-HT2A-receptor gene in fibromyalgia. Neurobiol Dis 1999;6:433-9. (Pubitemid 29496220)
25. Gursoy S, Erdal E, Herken H, Madenci E, Alasehirli B. Associa-tion of T102C polymorphism of the 5-HT2A receptor gene with psychiatric status in fibromyalgia syndrome. Rheumatol Int 2001; 21:58-61. (Pubitemid 33036132)
26. Tander B, Gunes S, Boke O, Alayli G, Kara N, Bagci H, et al. Polymorphisms of the serotonin-2A receptor and catechol-O-methyltransferase genes: a study on fibromyalgia susceptibility. Rheumatol Int 2008;28:685-91.
27. Eley TC, Sugden K, Corsico A, Gregory AM, Sham P, McGuffin P, et al. Gene-environment interaction analysis of serotonin system markers with adolescent depression. Mol Psychiatry 2004; 9:908-15. (Pubitemid 39381955)
28. Smith AK, Dimulescu I, Falkenberg VR, Narasimhan S, Heim C, Vernon SD, et al. Genetic evaluation of the serotonergic system in chronic fatigue syndrome. Psychoneuroendocrinology 2008;33: 188-97.
29. White KP, Ostbye T, Harth M, Nielson W, Speechley M, Teasell R, et al. Perspectives on posttraumatic fibromyalgia: a random survey of Canadian general practitioners, orthopedists, psychiatrists, and rheumatologists. J Rheumatol 2000;27:790-6.
30. Wolfe F. Stop using the American College of Rheumatology criteria in the clinic. J Rheumatol 2003;30:1671-2. (Pubitemid 36962441)
31. Ablin JN, Buskila D. Emerging therapies for fibromyalgia. Expert Opin Emerg Drugs 2008;13:53-62. (Pubitemid 351448702)
32. Barsky AJ, Wyshak G, Klerman GL. Medical and psychiatric determinants of outpatient utilization. Med Care 1986;24:548-60.
33. McBeth J, Chew-Graham C, Macfarlane GJ, Davies I, Jackson J, Creed F. The prevalence of "unexplained" chronic widespread pain in the general population: results from the General Practice Symptoms Study [abstract]. Rheumatology (Oxford) 2008;47 Suppl 2;ii184.
34. Office for National Statistics. 2001 Census: Standard Area Statistics (England and Wales). URL: www.statistics.gov.uk.